Comparison of Pathogenic Mechanisms Underlying Single and Recurrent Venous Thromboembolism Based on Gene Expression Profiling
- 1 October 2016
- journal article
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 36, 252-259
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Development of a Hypercoagulable Status in Patients Undergoing Off-Pump Lung Transplantation despite Prolonged Conventional Coagulation TestsAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patientsJournal of Trauma and Acute Care Surgery, 2014
- Dysfunction of protein C anticoagulant system, main genetic risk factor for venous thromboembolism in Northeast AsiansJournal of Thrombosis and Thrombolysis, 2013
- Incidence of and Mortality from Venous Thromboembolism in a Real-world Population: The Q-VTE Study CohortThe American Journal of Medicine, 2013
- Impaired tissue factor pathway inhibitor function is associated with recurrent venous thromboembolism in patients with first unprovoked deep venous thrombosisJournal of Thrombosis and Haemostasis, 2012
- New insights into the mechanisms of venous thrombosisJournal of Clinical Investigation, 2012
- Aspirin for Preventing the Recurrence of Venous ThromboembolismNew England Journal of Medicine, 2012
- Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolismThrombosis Research, 2011
- affy—analysis of Affymetrix GeneChip data at the probe levelBioinformatics, 2004
- The Epidemiology of Venous ThromboembolismCirculation, 2003